Triparanol is an antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible (covalent) cataracts. References: Officioso A, Manna C, Alzoubi K, Lang F. Triggering of Erythrocyte Death by Triparanol. Toxins (Basel). 2015 Aug 24;7(8):3359-71. doi: 10.3390/toxins7083359. PubMed PMID: 26305256; PubMed Central PMCID: PMC4549755.

纯度：≥98%

CAS：78-41-1